市场调查报告书
商品编码
1347958
全球医疗微控制器市场 - 2023-2030Global Medical Microcontroller Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球医疗微控制器市场2022年达到275亿美元,预计到2030年将达到483亿美元,2023-2030年预测期间复合年增长率为10.8%。
医疗微控制器在医疗设备中应用的增加有助于推动预测期内医疗微控制器的市场增长。近年来,医疗设备变得更加紧凑和便携,因此对小型医疗微控制器的需求不断增加。由于能够在医疗保健领域实现数据收集、通信和远程监控,因此需要医疗微控制器。
医疗微控制器在适应患者特定需求和条件的个性化医疗设备中发挥着重要作用。个性化医疗的日益增长趋势涉及针对个体患者量身定制治疗方案。具有连接功能的医疗设备(例如支持物联网的设备)为医疗微控制器提供了巨大的机会。
北美快速增长的医疗行业有助于推动预测期内医疗微控制器市场的市场增长。根据先进医疗技术协会的数据,美国是全球最大的医疗器械市场,占全球医疗器械市场的40%以上。人工智能和机器学习正在医疗行业迅速应用。
一些主要参与者在市场上推出了新产品。例如,2023年4月28日,美国Microchip Technology Inc.向市场推出了5个新的8位PIC和AVR MCU产品系列以及60多种新器件。新推出的产品AVR MCU和PIC可以轻鬆地与其他芯片进行通信。
微控制器是一种在单个集成电路封装上包含 ROM、RAM、CPU、时钟电路和 I/O 电路的设备。与传统微处理器类似,它的操作不需要附带的支持芯片。微控制器的优点是通过替换模拟电路,在软件中执行限幅器、整流器、比较器、积分器、微分器、对数放大器、有源滤波器和相敏解调器的信号处理功能。
例如,PIC18-Q40 系列是一款微控制器,提供的关键功能包括将PIC18 产品组合扩展到低引脚数、大闪存、小封装封装以及适用于便携式和空间受限设计的多用途模拟和数字CIP。该工具用于远程医疗和远程医疗护理、雾化器和注射泵中使用的医疗设备。根据美国医院协会的报告,大约 76% 的美国医院使用远程医疗与患者和医生进行远程联繫。
使用微控制器可以减少 IC 封装数量,从而降低复杂性并提供成本和空间优势。此外,它具有自校准和错误检测的能力,提高了生物医学仪器的可靠性。由于微控制器的硬件设计和板密度降低且维护成本低,因此它们主要用于便携式医疗设备。
增加医疗仪器的应用涉及利用技术和设备来增强医疗保健的各个方面。对远程患者监护的需求不断增长有助于推动医疗微控制器市场的发展。匹兹堡大学医学中心的数据显示,医疗行业的先进技术仪器使再入院风险降低了76%,患者满意度评分超过90%。
远程医疗在医疗保健行业的创新和采用激发了对医疗设备的需求。此外,医疗保健提供者和工作人员使用医疗设备来不断远程监控患者的健康状况和治疗情况。此外,不同的生物识别和可穿戴设备越来越受到年轻人的关注,并在日常医疗保健中流行起来,推动了医疗设备行业的新浪潮,并为医疗微控制器创造了潜在的商机
例如,据ABB公司称,可穿戴医疗设备市场预计复合年增长率为18%,从2021年的1158亿美元增长到2028年的3805亿美元。该行业的高度创新和竞争预计将在2028年创新新产品。未来,这最终也会创造对医疗微控制器的需求。微控制器 (MCU) 在各种便携式医疗仪器产品中发挥着重要作用。
医疗工业流程的自动化和工业 4.0 原理的实施正在推动对微控制器的需求。工业4.0主要关注医疗器械先进製造技术的集成。人工智能、机器人和物联网创建智能生产系统。微控制器在监控医疗保健行业中发挥着重要作用。
例如,2019 年 3 月,中国医生在 2000 英里外的手术台上使用远程手术工具在患者大脑中实施刺激装置。医疗机器人帮助因中风和其他神经系统疾病而部分瘫痪的患者。机器人中使用传感器和微控制器来检查人体状况。
与标准微控制器相比,医疗微控制器的成本较高,这是由于医疗应用所需的严格要求、专门设计和法规遵从性所致。影响医疗微控制器成本的一些因素包括设计和开发、法规遵从性、质量控制和认证。设计医疗微控制器需要额外的工程工作来确保可靠性、安全性和准确性。
医疗微控制器遵守 FDA 制定的严格监管标准和 IEC 60601 等国际标准。医疗微控制器的生产需要质量控制流程以确保患者安全。由于这些因素,医疗微控制器的成本很高。例如,PIC16F877A的成本为6.72美元/1个,ATMEGA328P的成本为4.98美元/1个,LPC1113FBD48的成本为2.24美元/1个。
Global Medical Microcontrollers Market reached US$ 27.5 billion in 2022 and is expected to reach US$ 48.3 billion by 2030, growing with a CAGR of 10.8% during the forecast period 2023-2030.
An increase in the applications of medical microcontrollers in medical devices helped to boost the market growth of medical microcontrollers over the forecast period. In recent years medical devices become more compact and portable hence the demand for small medical microcontrollers is increasing. Medical microcontrollers are required due to enabling data collection, communication and remote monitoring in healthcare.
Medical microcontrollers play an important role in personalized medical devices that adapt to patients' specific needs and conditions. The rising trend towards personalized medicine involves tailoring treatments to individual patients. Medical devices with the connectivity features, such as IoT-enabled devices offers tremendous opportunity for medical microcontrollers.
The rapidly growing medical industry in North America helps to boost the market growth of the medical microcontroller market over the forecast period. According to the data given by the Advanced Medical Technology Association, U.S. is the largest medical device market in the world accounted over 40% of the global medtech market. AI and machine learning are rapidly using in the medical industry.
Some of the major key players launched new products in the market. For instance, on April 28, 2023, Microchip Technology Inc., a U.S.-based company launched 5 new 8-bit PIC and AVR MCUs product families and over 60 new devices in the market. The newly launched products AVR MCUs and PIC are easily communicate with other chips.
Microcontrollers are a device that contains ROM, RAM, CPU, clock circuit and I/O circuity on a single integrated circuit package. It does not need accompanying support chips for its operation similar to conventional microprocessors. Microcontrollers have the advantage of performing the signal processing functions of a limiter, rectifier, comparator, integrator, differentiator, logarithmic amplifier, active filter and phase-sensitive demodulator in software by replacing analog circuits.
For instance, the PIC18-Q40 family is a microcontroller that offers key features including extending the PIC18 portfolio to low pin count with large flash memory, small footmark packages and multipurpose analog and digital CIPs for portable and space-constrained designs. The tool is used in medical devices used in telehealth and remote medical care, nebulizers and syringe pumps. As per the American Hospital Association reports, around 76% of U.S. hospitals use telehealth to connect remotely with patients and practitioners.
Using the microcontroller results in fewer IC packages which complexity reduces and provides cost and space benefits. Furthermore, It has the ability to self-calibration and detection of errors increasing the reliability of the biomedical instrument. Due to microcontrollers having diminished hardware design & board density and low-cost maintenance, they are mostly used in portable medical equipment.
Raping increasing the applications of medical instrumentation involves utilizing technology and devices to enhance various aspects of healthcare. Rising demand for remote patient monitoring helps to boost the medical microcontrollers market. According to the data given by the University of Pittsburgh Medical Center, advanced technological instruments in the medical industry reduce the risk of hospital readmissions by 76% and held patient satisfaction scores over 90%.
The innovation and adoption of telemedicine in the healthcare industry have inspired the demand for medical devices. Also, the medical devices used by healthcare providers and staff to endlessly monitor patient well-being and treatment situations remotely. Additionally, different biometric and wearable devices are gaining the attention of youths and becoming popular for use in day-to-day healthcare, providing a boost to a new wave of the medical devices industry and creating potential business opportunities for medical microcontroller
For instance, according to ABB company, the wearable medical devices market is expected to grow by CAGR of 18%, from US$ 115.8 Billion in 2021 to 380.5 Billion by 2028. High innovation and competative rivalary in this industry expacted to innovate new products in future, which will eventually create deamnd for medical microcontrollers as well. As microcontrollers (MCUs) are playing important role in a wide range of portable medical instrumentation products.
The automation of medical industrial processes and the implementation of Industry 4.0 principles are driving the demand for microcontrollers. Industry 4.0 majorly focuses on the integration of advanced manufacturing technologies of medical devices. Artificial intelligence, robotics and IoT create smart production systems. Microcontrollers play an important role in monitoring and controlling the healthcare industry.
For instance, in March 2019 Doctors in China used remote surgical tools for the implementation of stimulation devices in the patient's brain on an operating table that is 2,000 miles away. Healthcare robots help patients who have suffered partial paralysis due to stroke and other neurological conditions. Sensors and microcontrollers are used in the robots to examine human condition.
The higher cost of medical microcontrollers compared to standard microcontrollers is due to the stringent requirements, specialized design and regulatory compliance needed for the medical applications. Some of the factors affecting on the cost of medical microcontrollers are Design and Development, Regulatory Compliance, Quality Control and Certifications. Designing medical microcontrollers required extra engineering efforts for reliability, safety and accuracy.
Medical microcontrollers adhere to strict regulatory standards set by FDA and international standards like IEC 60601. The production of medical microcontrollers requires quality control processes for patients safety. Due to these factors medical microcontrollers have high cost. For instance, PIC16F877A has cost of US$ 6.72/1 pc, ATMEGA328P has cost of US$ 4.98/1 pc and LPC1113FBD48 has cost of US$ 2.24/1pc.
The global medical microcontrollers market is segmented based on type, application and region.
During forecast period 2022-2030, 16-bit microcontrollers is expected to dominate the global market with around 1/3rd share. Increase in the application of 16-Bit Microcontroller due to its low cost and power consumption. It gives higher processing power compared to 8-bit microcontrollers. The 16-Bit microcontroller is able to handle data manipulation, more complex algorithms and multitasking, which makes it suitable for moderate computational power applications.
The larger memory space of the 16-bit microcontrollers allows it for more extensive code storage. Also, an increase in product launches by major key players helps to boost segment growth over the forecast period. For instance, on October 16, 2021, Renesas Electronics Corporation, a supplier of advanced semiconductor solutions announced the launch of a 16-bit general-purpose RL78/G23 microcontroller. The new product launch further strengthens its RL78 Family of 8-bit and 16-bit MCUs for various applications.
North America medical microcontrollers market accounted largest market share of about 32.1% in 2022, due to the rapid growth in the medical devices industry. Due to this increase in the adoption and sales of medical microcontrollers. The rapid advancement in the patient monitoring devices, diagnostic equipment and implantable devices drives the need for high-performance microcontrollers with its advance features.
Due to the growing aging population in North America increase the demand of medical devices that aid in treatment, diagnostics and monitoring. The trend drives the demand for advanced microcontroller technology. According to the data given by U.S. Sensus Bureau, U.S.'s population age 65 and over grow nearly 5 times faster than the total population from 1920 to 2020. The older population in the region reached 55.8 million in U.S.
The major global players include: NXP Semiconductors, Renesas Electronics, Microchip Technology, Infineon Technologies, STMicroelectronics , Texas Instruments, GIE Media, Inc., Silicon Laboratories , Microchip Technology Inc. and Silicon Laboratories.
The COVID-19 pandemic has had a significant impact on economies and industries worldwide, including the medical microcontroller market. Medical microcontrollers are crucial components used in various electronic devices and systems. The outbreak of COVID-19 led to disruptions in global supply chains, affecting the production and availability of medical microcontrollers.
Lockdown measures, travel restrictions and factory closures implemented to contain the virus severely impacted the manufacturing and distribution processes. According to the International Monetary Fund (IMF), the global economy experienced a contraction of 3.5% in 2020 due to the pandemic.
Globally consumers are spending more time at home due to this there is increased demand for medical instruments. Rapid innovation in medical technology during the pandemic due to the urgent requirement of the patients. The market is negatively impacted due to disruptions in the supply chain, transportation restrictions and manufacturing challenges affecting the availability of components and materials used in medical microcontroller production.
The Russia-Ukraine conflict led to raw material shortages of medical microcontrollers due to the supply chain disruption which negatively impacted on the market growth. Ukraine is one of the major suppliers of raw materials used in medical microcontrollers manufacturing. Due to the disruption in supply chains raw materials required for medical microcontroller has been limited.
The shortage of raw materials has resulted in increased costs of medical microcontroller manufacturers. Ukraine, specifically, has a significant presence in the medical microcontroller industry, with several prominent semiconductor companies located within its borders. The conflict has led to disruptions in production and distribution channels, resulting in reduced availability of medical microcontrollers.
The ongoing conflict affected negatively on the medical microcontrollers market due to the supply chain disruptions and importand export restrictions. Due to this there is shortage of microcontrollers or components required for medical device manufacturing. Russia Ukraine affected zones facing challenges in the research and development of medical microcontroller. Due to the economic instability and uncertainty market is affected negatively due to the lack of funding and investments.
The global medical microcontrollers market report would provide approximately 53 tables, 47 figures and 202 pages.
LIST NOT EXHAUSTIVE